STERIS plc growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +8.7%
EBITDA: +34.6%
EBIT: +27.1%
EPS: +27.6%
Free cash flow: +25.0%
Operating cash flow: +16.8%

Forward estimates

Revenue: +8.7%
EBITDA: -6.0%
EPS: +42.5%

Three-year CAGR

Revenue: +9.4%
EBITDA: +8.9%
EBIT: +11.7%
Net income: +94.3%
EPS: +95.0%
Free cash flow: +35.0%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.